🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

Showing page 152 of 857 · Phase 3 first, then by program name

  1. RBC transfusion based on different protocols

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Transfusion Related Complication

    phase 3 other active

    1 trial

  2. RBP-6000

    Indivior Pty Ltd

    Opioid Use Disorder

    phase 3 small molecule completed

    4 trials

  3. RBP-7000

    Indivior Pty Ltd

    Schizophrenia

    phase 3 small molecule completed

    5 trials

  4. REC-2282

    RECURSION PHARMACEUTICALS, INC.

    Neurofibromatosis Type 2

    phase 3 small molecule terminated

    1 trial

  5. RECOMBINANT ADAMTS13 (rADAMTS13), RECOMBINANT ADAMTS13 (rADAMTS13)

    Baxalta Innovations GmbH

    Congenital Thrombotic thrombocytopenic purpura (cTTP)

    phase 3 small molecule active

    1 trial

  6. REGN10933 + REGN10987

    Regeneron UK Limited

    Healthy Participants

    phase 3 small molecule completed

    1 trial

  7. REGN1908

    Regeneron UK Limited

    Allergic Conjunctivitis

    phase 3 small molecule completed

    1 trial

  8. REGN1908-1909

    Regeneron UK Limited

    Allergic Rhinitis Due to Cat Allergy

    phase 3 small molecule terminated

    1 trial

  9. REGN2810

    Regeneron UK Limited

    Non-small Cell Lung Cancer

    phase 3 small molecule completed

    1 trial

  10. REGN2810/ipi

    Regeneron UK Limited

    Non-small Cell Lung Cancer

    phase 3 small molecule terminated

    1 trial

  11. REGN3918

    Regeneron UK Limited

    Paroxysmal Nocturnal Hemoglobinuria

    phase 3 small molecule terminated

    1 trial

  12. REGN4461 - Mibavademab

    Lacuna Pharma Pty Ltd

    Monogenic obesity

    phase 3 small molecule active

    1 trial

  13. REGN475

    Regeneron UK Limited

    Osteoarthritis, Knee

    phase 3 small molecule completed

    1 trial

  14. REGN5713

    Regeneron UK Limited

    Allergic Conjunctivitis

    phase 3 small molecule active

    2 trials

  15. REGN5713

    Regeneron UK Limited

    Allergic Rhinitis

    phase 3 small molecule completed

    2 trials

  16. REGN7508

    Regeneron UK Limited

    Venous Thromboembolism (VTE)

    phase 3 small molecule active

    2 trials

  17. REGN7508

    Regeneron UK Limited

    Peripheral Artery Disease (PAD)

    phase 3 small molecule active

    1 trial

  18. REGN7508

    Regeneron UK Limited

    Atrial Fibrillation (AF)

    phase 3 small molecule active

    2 trials

  19. REGN7508

    Regeneron UK Limited

    Symptomatic Venous Thromboembolism (VTE)

    phase 3 small molecule active

    1 trial

  20. REGN7508

    Regeneron UK Limited

    Cancer-Associated Thrombosis (CAT)

    phase 3 small molecule active

    1 trial

  21. REGN7508, CLEXANE 4 000 UI (40 mg)/0,4 ml solution injectable en seringue préremplie, Eliquis 2.5 mg film-coated tablets, SODIUM CHLORIDE, REGN7508

    Lacuna Pharma Pty Ltd

    Thromboembolic disease

    phase 3 small molecule active

    1 trial

  22. REL-1017

    RELMADA THERAPEUTICS, INC.

    Major Depressive Disorder

    phase 3 small molecule completed

    3 trials

  23. REN001

    OnKure Therapeutics

    Primary Mitochondrial Myopathy

    phase 3 small molecule terminated

    2 trials

  24. REOLYSIN

    ONCOLYTICS BIOTECH INC

    Carcinoma, Squamous Cell of the Head and Neck

    phase 3 mab completed

    2 trials

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources